Depreciation of Oncology Institute, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Oncology Institute, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Oncology Institute, Inc. Depreciation for the quarter ending 30 Sep 2025 was $1,006,000, a 26% increase year-over-year.
  • Oncology Institute, Inc. Depreciation for the twelve months ending 30 Sep 2025 was $3,981,000, a 30% increase year-over-year.
  • Oncology Institute, Inc. annual Depreciation for 2024 was $3,192,000, a 11% increase from 2023.
  • Oncology Institute, Inc. annual Depreciation for 2023 was $2,864,000, a 88% increase from 2022.
  • Oncology Institute, Inc. annual Depreciation for 2022 was $1,526,000, a 85% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Oncology Institute, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,981,000 $1,006,000 +$206,000 +26% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $3,775,000 $1,032,000 +$287,000 +39% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $3,488,000 $1,011,000 +$296,000 +41% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $3,192,000 $932,000 +$124,000 +15% 01 Oct 2024 31 Dec 2024 10-K 26 Mar 2025 2024 FY
Q3 2024 $3,068,000 $800,000 -$114,000 -12% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $3,182,000 $745,000 +$144,000 +24% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 $3,038,000 $715,000 +$174,000 +32% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 $2,864,000 $808,000 +$348,000 +76% 01 Oct 2023 31 Dec 2023 10-K 26 Mar 2025 2024 FY
Q3 2023 $2,516,000 $914,000 +$521,000 +133% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $1,995,000 $601,000 +$242,000 +67% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $1,753,000 $541,000 +$227,000 +72% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $1,526,000 $460,000 +$197,000 +75% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $1,329,000 $393,000 +$168,000 +75% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 $1,161,000 $359,000 +$186,000 +108% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $975,000 $314,000 +$149,000 +90% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q4 2021 $826,000 $263,000 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $225,000 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 $173,000 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $165,000 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1

Oncology Institute, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $3,192,000 +$328,000 +11% 01 Jan 2024 31 Dec 2024 10-K 26 Mar 2025 2024 FY
2023 $2,864,000 +$1,338,000 +88% 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2025 2024 FY
2022 $1,526,000 +$700,000 +85% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 $826,000 +$135,000 +20% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2020 $691,000 01 Jan 2020 31 Dec 2020 10-K 11 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.